What Is Zoryve, and Why Does It Matter?
Zoryve (roflumilast) cream 0.3% is a steroid‑free anti‑inflammatory medicine you apply on the skin. The FDA has approved it to be used in children as young as 2 years old to treat plaque psoriasis on the skin, including in areas with skin folds.
Zoryve works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation signals in skin cells. Plaque psoriasis is a common and long‑lasting skin condition. In the United States, it affects nearly 9 million people. It often causes itching, redness, flaking, and scaling. Psoriasis can appear almost anywhere, including on thin or sensitive skin such as on the face and genitals and places where skin touches skin.
This approval allows broader use of this medicine in younger kids. Zoryve is the first steroid‑free, once‑daily option for plaque psoriasis cleared for children as young as 2 years old. Earlier, Zoryve cream 0.3% was approved for treating plaque psoriasis in adults and children 6 or older.
The manufacturing company also reports that it can be applied anywhere on the body and does not have a set time limit for use. Many steroid creams are avoided on thin skin and for continuous long‑term use due to side effects. Having a steroid‑free choice you can use on sensitive areas may help close a treatment gap for families.
Zoryve cream (0.15% and 0.05%) is also used to treat mild to moderate eczema (atopic dermatitis) in adults and children ages 2 years and older, with different strengths approved for different age groups.
Why Was It Approved?
The FDA has expanded the use of Zoryve to include children aged 2-5 years based on research in young kids. In a four‑week study, children aged 2-5 used Zoryve cream 0.3%. Researchers checked how much medicine was absorbed in the body (pharmacokinetic studies), and they followed safety, tolerability, and early signs of benefit. Some children in the study were observed for up to 24 weeks. Findings in these younger children were generally similar to results seen in older groups.
Evidence from older children and adults also supported the decision. In studies involving participants aged 6 years or older with plaque psoriasis, more individuals had clear or almost clear skin at week 8 with Zoryve than with placebo.
A low incidence (about 1%-3%) of side effects were seen in studies with Zoryve cream, including diarrhea, headache, trouble sleeping, nausea, pain or burning at the application site, colds, and urinary tract infections.
What Do I Need to Know?
Apply a thin layer of Zoryve cream 0.3% to your or your child’s affected skin once each day. Rub it in fully, then wash your hands. Use it only on skin. Do not apply it to your or your child’s eyes, mouth, or vagina. Do not use Zoryve if you or your child has moderate-to-severe liver problems. If you are unsure about your or your child’s liver health, speak to your health care provider.
Some medicines can raise roflumilast levels and increase side effects. Strong inhibitors of an enzyme called CYP3A4 or medicines that block both CYP3A4 and CYP1A2 can raise levels. Certain birth control pills can also raise levels. Tell your health care provider and pharmacist about every medicine, supplement, and herbal remedy you or your child takes.
It is not known whether Zoryve can harm a fetus. If you breastfeed, use the smallest amount of the medicine on the smallest area for the shortest time you need. Do not put the cream on the nipple or areola, and keep treated skin away from direct contact with your baby.